Eli Lilly has launched new single-dose 2.5mg and 5.0mg vials of its obesity drug Zepbound in a move that ... via the company's LillyDirect direct-to-consumer self-pay channel – are "at least ...

With its weight-loss fetish and direct-to-consumer marketing ... Indiana-based Eli Lilly rolled out its own GLP-1 drugs, Mounjaro and Zepbound. With an American company invading Novo’s market ...

SAN FRANCISCO — When Eli Lilly last year started offering lower-priced vials of its blockbuster obesity drug Zepbound, which were previously sold in injectable pens, it framed the move as a way ...

Eli Lilly also states that vial forms are cheaper than the auto-injector pre-filled pens. It also means you will be better protected against buying counterfeit or compounded Zepbound. Zepbound in ...

Best of luck, and do keep in touch. … When Eli Lilly last year started offering lower-priced vials of its blockbuster obesity drug Zepbound, which were previously sold in injectable pens ...

In 2024, Eli Lilly started offering single-dose vials, as opposed to the auto-injector pen that the drug typically comes in, at a cheaper price. A four-week supply of the 2.5 mg Zepbound single ...

In a recent press release, Eli Lilly's management said that the U.S. incretin market, which includes drugs like Zepbound and Mounjaro, didn't grow as fast as it anticipated in the fourth quarter.